Unicycive Therapeutics Q3 EPS $(0.25) Beats $(0.31) Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 24.24 percent increase over losses of $(0.33) per
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 24.24 percent increase over losses of $(0.33) per share from the same period last year.
